Metered Dose Inhalers of Fluticasone or an Ester Thereof
Summary
The USPTO published patent application US20260091182A1 for a metered dose inhaler comprising a stable pharmaceutical composition of fluticasone or its ester. The application, filed December 5, 2025, with six named inventors, covers the composition, manufacturing process, and use in treating respiratory disorders including asthma. The invention includes a canister with metering valve, actuator, and dose counter.
What changed
The USPTO published application US20260091182A1 (Application No. 19410585) for a metered dose inhaler containing fluticasone or a pharmaceutically acceptable ester thereof. The claimed invention comprises a stable pharmaceutical composition in a canister fitted with a metering valve, an actuator, and a dose counter. CPC classifications include A61M 15/009, A61K 9/008, A61K 31/56, A61M 15/0068, and A61M 2205/0238, covering respiratory devices, pharmaceutical compositions, and drug delivery systems.\n\nPatent applications do not impose compliance obligations on regulated entities. No deadlines, penalties, or required actions apply. Pharmaceutical and medical device companies may monitor this application to assess potential future competition in the inhaled corticosteroid inhaler space. The application remains pending and subject to examination.
Archived snapshot
Apr 2, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
METERED DOSE INHALERS OF FLUTICASONE OR AN ESTER THEREOF
Application US20260091182A1 Kind: A1 Apr 02, 2026
Inventors
Julianne BERRY, Rajesh ANKAM, Sushrut KULKARNI, Michael CRICK, Hemant PAWAR, Rajesh RAIKAR
Abstract
The invention relates to metered dose inhaler comprising a stable pharmaceutical composition of fluticasone or its pharmaceutically acceptable ester contained in a canister fitted with a metering valve, an actuator and dose counter. The invention also relates to a process for preparing said pharmaceutical composition and its use in the treatment of respiratory disorders such as asthma in a subject (e.g., a human).
CPC Classifications
A61M 15/009 A61K 9/008 A61K 31/56 A61M 15/0068 A61M 2205/0238
Filing Date
2025-12-05
Application No.
19410585
Named provisions
Related changes
Get daily alerts for ChangeBridge: Patent Apps - Medical Devices (A61M)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ChangeBridge: Patent Apps - Medical Devices (A61M) publishes new changes.